Areas of High 18F-FDG Uptake on Preradiotherapy PET/CT Identify Preferential Sites of Local Relapse After Chemoradiotherapy for Non–Small Cell Lung Cancer

Authors:

Abstract
Rationale: The high rates of failure in the radiotherapy target volume suggest that patients with stage II-III non-small-cell lung cancer (NSCLC) should receive increased radiotherapy total dose. High 18Fluoro-2-deoxy-D-glucose (18F-FDG) uptake areas (hotspot) on pre-radiotherapy 18F-FDG positron emission tomography /computed tomography (PET/CT) have been reported to identify intra-tumor sub-volumes at high risk of relapse after radiotherapy. We wanted to confirm these observations on a cohort of patients included in three sequential prospective studies. Our aim was to assess an appropriate threshold (% of SUVmax) to delineate sub-volumes on staging 18F-FDG PET/CT assuming that a smaller target volume would facilitate isotoxic radiotherapy dose escalation. Methods: 39 patients with inoperable stage II-III NSCLC, treated with chemo-radiation or with radiotherapy alone, were extracted from 3 prospective studies (ClinicalTrials.gov Identifier NCT01261585, NCT01261598, RECF0645). All patients underwent 18F-FDG PET/CT scans at initial staging, before radiotherapy, during radiotherapy, and during systematic follow-up in a single institution. All 18F-FDG PET/CT acquisitions were co-registered on the initial scan. Various sub-volumes in the initial (30, 40, 50, 60, 70, 80 and 90% SUVmax) and in the 3 subsequent acquisitions (40% and 90% SUVmax thresholds) were pasted on the initial scan and compared. Results: 17 patients had a local relapse (LR). The SUVmax measured during radiotherapy was significantly higher in LR tumors than in the locally-controlled tumors (mean: 6.8 vs. 4.6; P = 0.02). The sub-volumes delineated on initial PET/CT with 70 to 90% SUVmax threshold were in good agreement with the recurrent volume at 40%SUVmax (common volume/baseline volume = 0.60 to 0.80). The sub-volumes delineated on initial PET/CT with 30 to 60% SUVmax were in good to excellent agreement with the core volume of the relapse (90% SUVmax) (common volume/recurrent volume and OF indices 0.60 to 0.93). The agreement was moderate (>0.51) when a 70 % SUVmax threshold was used to delineate on initial PET/CT. Conclusion: High 18F-FDG uptake areas on pre-treatment PET/CT identify tumor sub-volumes at greater risk of relapse in patients with NSCLC treated by concomitant chemo-radiation. We propose a 70% SUVmax threshold to delineate high 18F-FDG uptake areas on initial PET/CT as target volumes for potential radiotherapy dose escalation.

This publication has 26 references indexed in Scilit: